<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>0212-1611</journal-id>
<journal-title><![CDATA[Nutrición Hospitalaria]]></journal-title>
<abbrev-journal-title><![CDATA[Nutr. Hosp.]]></abbrev-journal-title>
<issn>0212-1611</issn>
<publisher>
<publisher-name><![CDATA[Grupo Arán]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S0212-16112007000100011</article-id>
<title-group>
<article-title xml:lang="en"><![CDATA[Modulatory effects of N-acetylcysteine on cerebral cortex and cerebellum regions of ageing rat brain]]></article-title>
<article-title xml:lang="es"><![CDATA[Efectos moduladores de la N-acetilcisteína sobre la corteza cerebral y las regiones cerebelosas sobre la del cerebro senescente de rata]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Singh Kanwar]]></surname>
<given-names><![CDATA[S.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Nehru]]></surname>
<given-names><![CDATA[B.]]></given-names>
</name>
<xref ref-type="aff" rid="A01"/>
</contrib>
</contrib-group>
<aff id="A01">
<institution><![CDATA[,Panjab University Department of Biophysics ]]></institution>
<addr-line><![CDATA[Chandigarh ]]></addr-line>
<country>India</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>02</month>
<year>2007</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>02</month>
<year>2007</year>
</pub-date>
<volume>22</volume>
<numero>1</numero>
<fpage>95</fpage>
<lpage>100</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_arttext&amp;pid=S0212-16112007000100011&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_abstract&amp;pid=S0212-16112007000100011&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://scielo.isciii.es/scielo.php?script=sci_pdf&amp;pid=S0212-16112007000100011&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="en"><p><![CDATA[Oxidative stress has been implicated in brain ageing and in age-related neurodegenerative disorders. Since Nacetylcysteine (NAC) has recently been shown to prevent oxidative damage in ageing brain, we have examined the effects of this thiolic antioxidant on the age associated oxidative stress related parameters in rat brain regions. The lipid peroxide formation, reduced glutathione (GSH) content along with the activities of superoxide dismutase (SOD) and catalase were determined in the cerebral cortex and cerebellum brain regions of the young (4 months) and older (14 months) female rats. The lipid peroxidation was observed to be increased in the cerebral cortex regions accompanied by simultaneous decrease in the GSH content in both the regions of older rats. The SOD activity was reduced in both the regions while catalase was reduced only in cerebellum region of the older rats. Following NAC supplementation (160 mg/kg. b. wt./ day), lipid peroxidation was observed to be reduced which was accompanied by enhanced GSH levels, along with enhanced SOD and catalase in both the brain regions of older rats. Further, in the younger rats the NAC treatment resulted in the decrease of lipid peroxidation in both the regions that was accompanied by the increase catalase activity in cerebral cortex region along with increase in GSH content and SOD in cerebellum regions. Our result suggests that the normal brain ageing is associated with the decrease in antioxidative defense status and the supplementation of thiol antioxidants like NAC may prove helpful in managing the age related brain disorders characterized by compromised antioxidative defense systems.]]></p></abstract>
<abstract abstract-type="short" xml:lang="es"><p><![CDATA[El estrés oxidativo se ha implicado en el envejecimiento cerebral y en los trastornos neurodegenerativos asociados con la edad. Puesto que recientemente se ha demostrado que la N-acetilcisteína (NAC) previene el daño oxidativo en el cerebro senescente, hemos explorado los efectos de este antioxidante tiólico sobre los parámetros relacionados con el estrés oxidativo asociado al envejecimiento cerebral en regiones cerebrales de la rata. La formación de peróxidos lipídicos, la reducción en el contenido de glutatión (GSH), junto con las actividades de la superóxido dismutasa (SOD) y catalasa se determinaron in las regiones cerebrales corticales y cerebelosas de ratas hembra jóvenes (4 meses) y viejas (14 meses). La peroxidación lipídica se observó aumentada en las regiones de la corteza cerebral junto con un descenso simultáneo del contenido en GSH en ambas regiones de las ratas viejas. La actividad de la SOD estaba reducida en ambas regiones mientras que la catalasa estaba disminuida sólo en la región cerebelosa de las ratas viejas. Tras el suplemento con NAC (160 mg/kg de peso/ día), se observó que la peroxidación lipídica disminuía, lo que se acompañó de concentraciones aumentadas de GSH junto con aumento de SOD y catalasa en ambas regiones cerebrales de las ratas viejas. Además, en las ratas jóvenes, el tratamiento con NAC produjo una disminución de la peroxidación lipídica en ambas regiones acompañada de un aumento de la actividad catalasa en la región de la corteza cerebral junto con un aumento del contenido en GSH y SOD en la región del cerebelo. Nuestros resultados sugieren que el envejecimiento cerebral normal se asocia con una disminución del estado defensivo antioxidante y que la complementación con antioxidantes tiólicos como la NAC podría mostrarse útil en el tratamiento de los trastornos cerebrales relacionados con la edad y caracterizados por una alteración de los sistemas defensivos antioxidantes.]]></p></abstract>
<kwd-group>
<kwd lng="en"><![CDATA[N-Acetylcysteine]]></kwd>
<kwd lng="en"><![CDATA[Reduced glutathione]]></kwd>
<kwd lng="en"><![CDATA[Lipid peroxidation]]></kwd>
<kwd lng="en"><![CDATA[Antioxidative defense]]></kwd>
<kwd lng="en"><![CDATA[Brain ageing]]></kwd>
<kwd lng="es"><![CDATA[N-Acetilcisteína]]></kwd>
<kwd lng="es"><![CDATA[Glutatión reducido]]></kwd>
<kwd lng="es"><![CDATA[Peroxidación lipídica]]></kwd>
<kwd lng="es"><![CDATA[Defensa antioxidante]]></kwd>
<kwd lng="es"><![CDATA[Envejecimiento cerebral]]></kwd>
</kwd-group>
</article-meta>
</front><body><![CDATA[ <p align="right"><font size="2" face="Verdana"><b>ORIGINAL</b></font></p>     <p>&nbsp;</p>     <p><font face="Verdana" size="4"><b><a name="top"></a>Modulatory effects of N-acetylcysteine on cerebral cortex and cerebellum regions of ageing rat brain</b></font></p>     <p><font face="Verdana" size="4"><b>Efectos moduladores de la N-acetilcisteína sobre la corteza cerebral y las regiones cerebelosas sobre la del cerebro senescente de rata</b></font></p>     <p>&nbsp;</p>     <p>&nbsp;</p>     <p><font size="2" face="Verdana"><b>S. Singh Kanwar and B. Nehru<sup>*</sup></b></font></p>     <p><font size="2" face="Verdana">Department of Biophysics. Panjab University. Chandigarh. India.</font></p>     <p><font size="2" face="Verdana"><a href="#back">Correspondence</a></font></p>     <p>&nbsp;</p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p>  <hr size="1">     <p><b><font size="2" face="Verdana">ABSTRACT</font></b></p>     <p><font size="2" face="Verdana">Oxidative stress has been implicated in brain ageing and in age-related neurodegenerative disorders. Since Nacetylcysteine (NAC) has recently been shown to prevent oxidative damage in ageing brain, we have examined the effects of this thiolic antioxidant on the age associated oxidative stress related parameters in rat brain regions. The lipid peroxide formation, reduced glutathione (GSH) content along with the activities of superoxide dismutase (SOD) and catalase were determined in the cerebral cortex and cerebellum brain regions of the young (4 months) and older (14 months) female rats. The lipid peroxidation was observed to be increased in the cerebral cortex regions accompanied by simultaneous decrease in the GSH content in both the regions of older rats. The SOD activity was reduced in both the regions while catalase was reduced only in cerebellum region of the older rats. Following NAC supplementation (160 mg/kg. b. wt./ day), lipid peroxidation was observed to be reduced which was accompanied by enhanced GSH levels, along with enhanced SOD and catalase in both the brain regions of older rats. Further, in the younger rats the NAC treatment resulted in the decrease of lipid peroxidation in both the regions that was accompanied by the increase catalase activity in cerebral cortex region along with increase in GSH content and SOD in cerebellum regions. Our result suggests that the normal brain ageing is associated with the decrease in antioxidative defense status and the supplementation of thiol antioxidants like NAC may prove helpful in managing the age related brain disorders characterized by compromised antioxidative defense systems.</font></p>     <p><font size="2" face="Verdana"><b>Key words:</b> N-Acetylcysteine. Reduced glutathione. Lipid peroxidation. Antioxidative defense. Brain ageing.</font></p> <hr size="1">      <p><font size="2" face="Verdana"><b>RESUMEN</b></font></p>     <p><font size="2" face="Verdana">El estr&eacute;s oxidativo se ha implicado en el envejecimiento cerebral y en los trastornos neurodegenerativos asociados con la edad. Puesto que recientemente se ha demostrado que la N-acetilciste&iacute;na (NAC) previene el da&ntilde;o oxidativo en el cerebro senescente, hemos explorado los efectos de este antioxidante ti&oacute;lico sobre los par&aacute;metros relacionados con el estr&eacute;s oxidativo asociado al envejecimiento cerebral en regiones cerebrales de la rata. La formaci&oacute;n de per&oacute;xidos lip&iacute;dicos, la reducci&oacute;n en el contenido de glutati&oacute;n (GSH), junto con las actividades de la super&oacute;xido dismutasa (SOD) y catalasa se determinaron in las regiones cerebrales corticales y cerebelosas de ratas hembra j&oacute;venes (4 meses) y viejas (14 meses). La peroxidaci&oacute;n lip&iacute;dica se observ&oacute; aumentada en las regiones de la corteza cerebral junto con un descenso simult&aacute;neo del contenido en GSH en ambas regiones de las ratas viejas. La actividad de la SOD estaba reducida en ambas regiones mientras que la catalasa estaba disminuida s&oacute;lo en la regi&oacute;n cerebelosa de las ratas viejas. Tras el suplemento con NAC (160 mg/kg de peso/ d&iacute;a), se observ&oacute; que la peroxidaci&oacute;n lip&iacute;dica disminu&iacute;a, lo que se acompa&ntilde;&oacute; de concentraciones aumentadas de GSH junto con aumento de SOD y catalasa en ambas regiones cerebrales de las ratas viejas. Adem&aacute;s, en las ratas j&oacute;venes, el tratamiento con NAC produjo una disminuci&oacute;n de la peroxidaci&oacute;n lip&iacute;dica en ambas regiones acompa&ntilde;ada de un aumento de la actividad catalasa en la regi&oacute;n de la corteza cerebral junto con un aumento del contenido en GSH y SOD en la regi&oacute;n del cerebelo. Nuestros resultados sugieren que el envejecimiento cerebral normal se asocia con una disminuci&oacute;n del estado defensivo antioxidante y que la complementaci&oacute;n con antioxidantes ti&oacute;licos como la NAC podr&iacute;a mostrarse &uacute;til en el tratamiento de los trastornos cerebrales relacionados con la edad y caracterizados por una alteraci&oacute;n de los sistemas defensivos antioxidantes.</font></p>     <p><font size="2" face="Verdana"><b>Palabras clave:</b> N-Acetilciste&iacute;na. Glutati&oacute;n reducido. Peroxidaci&oacute;n lip&iacute;dica. Defensa antioxidante. Envejecimiento cerebral.</font></p>  <hr size="1">     <p>&nbsp;</p>     <p><b><font face="Verdana" size="3">Introduction</font></b></p>     <p><font size="2" face="Verdana">Ageing can be defined as the nonfunctional alteration of structure or homeostatic capability in an individual organism as it lives<sup>1</sup>. Oxygen free radicals and oxidative events have been implicated as playing a role in bringing about the changes in cellular function that occur during ageing<sup>2-4</sup>. The normal redox status of a cell which regulates several cellular processes such as signal transduction, gene expression, cell proliferation and cell death (neurotic and apoptotic) is usually maintained by the two opposing factors antioxidants and oxidants produced during the normal cellular metabolism<sup>5</sup>. Glutathione and thioredoxin are two such intracellular antioxidants in addition to other antioxidants obtained from the diet like Vitamin E, ascorbic acid and essential metals that help in normalizing the ageing induced alterations<sup>6,7</sup>.</p>     ]]></body>
<body><![CDATA[<p>For a long time dietary antioxidants are considered to be important means for fighting ageing processes<sup>8</sup>. Hence, it is of utmost importance to know what kind of antioxidants and free radical scavengers could be most effective for ageing delay. Previously, we reported the use of N-acetylcysteine (NAC) in reducing the oxidative stress in rat brains produced during lead exposure<sup>9</sup>. NAC, a thiol compound having the formula C5H9O3S, is an excellent source of sulfhydryl (SH) groups that stimulates the reduced glutathione (GSH) synthesis, promotes detoxification and act directly as free radical scavengers<sup>10</sup>. NAC have beneficial effects in conditions characterized by decreased GSH or oxidative stress such as HIV infection, cancer, heart disease and cigarette smoking. The sulfhydryl (SH) group is responsible for a great deal of the metabolic activity of NAC, while the acetyl-substituted amino group makes the molecule more stable against oxidation<sup>11</sup>. SH groups are essential for defense against reactive oxygen species. So it is not surprising that NAC is a powerful scavenger of hypochlorous acid, and is capable of reducing hydroxyl radicals and hydrogen peroxide<sup>12</sup>. However, progress in elucidating the evaluation of NAC efficacies on brain regions in modulating the age associated oxidative stress so far is slow. The present work is an attempt in this direction. For this, the age associated alterations on the lipid peroxides and antioxidant enzyme status in brain regions (cerebral cortex and cerebellum) were determined in two groups of animals belonging to different ages along with and without NAC supplementation.</font></p>     <p>&nbsp;</p>     <p><font face="Verdana"><b>Materials and methods</b></p></font><font size="2" face="Verdana">     <p><i>Animals and treatments</i></p>     <p>Healthy female rats of the Wistar strain of 4 months old and 14 months old were obtained from the central animal house of Panjab University. The animals were housed in polypropylene cages under hygienic conditions and were provided standard animal feed and water ad libitum throughout the treatment duration of three weeks. All procedures were done in accordance with ethical guidelines for care and use of laboratory animals and were approved by the Animals Ethics Committee of Panjab University. For the present study, a total of 30 animals were used which were divided into two groups: age group I (4 months old) and age group II (14 months old) with 15 animals each. Both the groups were administered NAC (160 mg/kg b. wt., dissolved in physiological saline) intraperitoneally once a day for three weeks. Respective control of both the age groups were also run in parallel and were injected the same volume of saline. The animals were monitored regularly for their physical activity and general health and a weekly weight changes were recorded.</p>      <p><b>    <br> </b><i>Tissue Preparations</i></p>     <p>At the end of various treatments, the animals of each group were anesthetized with ether and sacrificed by decapitation; the brains were removed, rinsed in icecold isotonic saline, and cerebral cortex and cerebellum regions were dissected. A 10% (w/v) tissue homogenate was prepared in ice-cold 10 mM PBS (Phosphate-buffered saline, 0.15 M NaCl), pH 7.4. The homogenate was centrifuged at 1.000 g for 10 min. at 4&deg;C and the supernatant was used for biochemical assays. For the superoxide dismutase assay, the supernatant was further centrifuged at 12,000 g for 20 min.</p>      <p><b>    <br> </b><i>Biochemical Estimations</i></p>     ]]></body>
<body><![CDATA[<p>The quantitative measurement of lipid peroxidation was performed according to the methods of Wills<sup>13</sup>. The malondialdehyde formed was measured by the reaction with thiobarbituric acid at 532 nm. The results were expressed as nmol malondialdehyde/ mg protein using the molar extinction coefficient malondialdehyde- thiobarbituric chromophore (1.56X 105M<sup>-1</sup> cm <sup>-1</sup>). The reduced glutathione (GSH) content was estimated according to the method of Ellman<sup>14</sup>. In this method 5,5-dithiobis2-nitrobenzoic acid (DTNB) is reduced by -SH groups to form 1 mole of 2-nitro-5-mercaptobenzoic acid per mole of SH. The nitro mercaptobenzoic acid anion released has an intense yellow color and can be used to measure -SH groups at 412 nm. The superoxide dismutase (SOD) assay was performed according to the method of Kono<sup>15</sup>. The extent of inhibition of reduction of Nitro Blue Tetrazolium (NBT) to blue formazon, by the addition of the enzyme was measured at 560 nm. The activity of enzyme was expressed as units/ mg protein, where one unit of enzyme is defined as the amount of enzyme inhibiting the rate of reaction by 50%. Catalase was assayed according to the method of Luck<sup>16</sup>, the breakdown of H<sub>2</sub>O<sub>2</sub> being measured at 240 nm. The results were expressed as mmol H<sub>2</sub>O<sub>2</sub> decomposed/ min/ mg protein. Proteins were estimated in the samples by the method of Lowry et al.<sup>17</sup>.</p>      <p><b>    <br> </b><i>Statistical Analysis</i></p>     <p>Tabulated values represent means &plusmn; SD. One-way analysis of variance (ANOVA) and the Student-Newman- Keuls multiple comparison tests were used to analyze data from experimental and control groups. Values with p less than 0.05 were considered significant.</p>     <p>&nbsp;</p></font><font face="Verdana">     <p><b>Results</b></p></font><font size="2" face="Verdana">     <p>In cerebral cortex region, lipid peroxides showed highly significant increase (p &lt; 0.001) with age while no change was observed in cerebellar region when their respective controls are compared. The percentage increase in the lipid peroxides in cerebral cortex region in control of older rats (age group-II) was to an extent of 40.6% when compared to control of young rats (age group-I). However, NAC supplementation resulted in highly significant decrease (p &lt; 0.001) in the lipid peroxides in both the cerebral cortex region and cerebellar region in both the age group-I rats (43.8% and 76.7% respectively) and age group-II rats (86.7% and 81.6% respectively) but to greater extent in older rats (See <a target="_blank" href="/img/revistas/nh/v22n1/9_t1.gif">table I</a>).</p>     <p>A significant decrease in the GSH content was observed in the control of age group II animals in both the cerebral cortex (57.2%) and cerebellum region (80.1%) of rat brains. After NAC supplementation to young animals, the glutathione was increased in the cerebellum region only to an extent of 25.4%, whereas, NAC treatment to age group II animals resulted in enhanced glutathione levels in both the cerebral cortex (207.4%) and cerebellum regions (146.8%) (See <a target="_blank" href="/img/revistas/nh/v22n1/9_t2.gif">table II</a>).</p>     <p>As a result of ageing SOD activity showed highly significant decline (p &lt; 0.001) in cerebral cortex as well as cerebellum region. The older age group-II rats showed the decline in SOD activity to an extent of 49.2% in cerebral cortex and 71.5% in cerebellum region when its control is compared to control of younger age group-I rats. In cerebral cortex, the supplementation of NAC produced no significant change in SOD activity in younger age group-I rats, while in older age group-II rats it resulted a highly significant increase (p &lt; 0.001) in SOD noted to an extent of 72.6%. Further, in cerebellum region both the age group-I and age group-II showed enhanced SOD activity following NAC supplementations. The percentage increase in SOD activity due to NAC treatment was observed to more extent in older age group-II (154.5%) than that of younger age group-I (30.1%) (See <a target="_blank" href="/img/revistas/nh/v22n1/9_t3.gif">table III</a>).</p>     <p>The cerebral cortex showed no alterations in catalase activities while cerebellum region showed significant decline (p &lt; 0.001) in catalase activity with age when the control of old age group II animals were compared with the control of young animals. NAC treatment in cerebral cortex region produced significant increase in catalase activity in both the age group-I (p &lt; 0.05) and age group-II (p &lt; 0.001) rats. The increase in catalase activity following NAC supplementation was found to more extent in older rats of age group-II (479.6%) than in young age group-I rats (45.6%). In cerebellar region NAC treatment to younger age group-I rats produced no significant change in catalase activity in while it resulted in highly significant increase (p &lt; 0.001) in catalase activity in older age group-II rats (See <a target="_blank" href="/img/revistas/nh/v22n1/9_t4.gif">table IV</a>).</p>     ]]></body>
<body><![CDATA[<p>&nbsp;</p></font><font face="Verdana">     <p><b>Discussion</b></p></font><font size="2" face="Verdana">     <p>In multicellular organisms, ageing processes are associated with progressive degeneration of biological functions and increased susceptibility to diseases. Finding new treatments, and eventually cures, for the diseased conditions arising during ageing is therefore a priority. Damage due to free radicals is a major contributor to ageing<sup>2,3,4</sup>.</font></p>      <p ><font size="2" face="Verdana">Lipid peroxidation has been identified as a basic deteriorative reaction in the cellular mechanism of the ageing<sup>18,19</sup>. Lipid peroxidation is initiated by the free radicals which oxidize the polyunsaturated fatty acids leading to the formation of conjugate dienes ultimately resulting in the production of hydroperoxides, cyclic peroxides and malonylaldehyde. Acting as the first line of defense against the production of such hydroperoxides is a naturally occurring antioxidant glutathione (GSH), which is a major source of free thiol in most living cells. GSH in addition also participates in diverse biological processes such as the detoxification of xenobiotics and modulation of enzyme activity by disulphide interchange<sup>20</sup>. In the present experiments, enhanced MDA levels were observed in cerebral cortex region of older age group, along with the decline in GSH content in both the brain regions, thus implicating the role of lipid peroxidation associated with simultaneous decline of GSH in the process of normal ageing. These results are in agreement with those of Leutner et al<sup>21</sup>, Smith et al<sup>21</sup> and Rodriguez-Martinez et al<sup>20</sup> who observed the reaction products of active oxygen such as lipofuscin and lipid peroxide increases with ageing. These effects are due to continuous presence of small concentration of oxygen free radicals in the tissues during ageing<sup>19,22</sup> which eventually leads to the imbalance in cellular redox status. In the present study, these changes were further reflected in the GSH concentration which decreased during ageing. Alterations in the normal GSH status influence the normal redox status of the cell and hence may lead to lipid peroxidation<sup>23</sup>. Study in the ageing animal by Ravindranath et al<sup>24</sup> and Hazelton and Lang<sup>25</sup> had also indicated a low GSH content as a general phenomenon of aging brain and other ageing tissues.</p>     <p>The NAC supplementations to both the age groups proved beneficial in terms of lowering the MDA levels in brain regions accompanied by the increase levels of GSH in both the regions of older age group and in cerebellum region in case of younger rats. The decline in MDA levels due to NAC treatment is observed to greater extent in older age group (decline of 86.7% in cerebral cortex and 81.6% in cerebellum region). The increase in GSH levels following NAC supplementation in brain regions is due to the increased availability of cysteine, which is essentially required for the GSH synthesis<sup>26</sup>. Experimental results by De Flora et al<sup>27</sup>, Hoffer et al<sup>28</sup> and Issels et al<sup>29</sup> have also pointed the increases intracellular concentrations of GSH following NAC supplementations. The results reported here clearly indicates that the increase GSH concentration by NAC has contributed towards the decrease lipid peroxidation in the brain regions by improving the glutathione redox status which helps in maintaining the normal metabolic activity of the cell during ageing process.</p>     <p>Active oxygen species have been proposed to be involved in the ageing process of body. Perez-Campo et al<sup>30</sup> suggested the continuous presence of small concentrations of oxygen radicals in the tissues throughout the life span of animals to be contributing to ageing. SOD and catalase are both antioxidant enzymes that function as blockers of free radical process<sup>31</sup>. In the present study, older age group showed significant decline in SOD activity in both the brain regions (decline of 49.2% in cerebral cortex and 71.5% in cerebellum), whereas, catalase showed significant decline only in the cerebellum region of its older age group (decline of 50.8%). Semsci et al<sup>32</sup> studied the age dependent activities of various enzymes involved in the protection against active oxygen species in rat brain and reported the decrease in enzyme activity as a result of reduced enzyme synthesis processes with age. The gradual decrease in catalase with increasing age appears to be due to an age-dependent change in the expression of their genes<sup>33</sup>. Following NAC supplementation both SOD and catalase, showed significant increase in their activities in older age group. NAC through its thiol group acts as a scavenger of free radicals involved in the process of cellular ageing and therefore helps in maintaining the normal cellular metabolic state. The observed increase in antioxidant enzymes activity may be due to the direct consequences of the improved redox homeostasis following NAC administration and, resulting into the better enzymes synthesis in older age group.</p>     <p>In summary, the results from the present study suggest that supplementation of extraneous antioxidants and free radical scavengers like NAC may be useful in combating the free radical induced harmful effects during ageing processes.</p>     <p>&nbsp;</p></font><font face="Verdana">     <p><b>References</b></font></p>     <!-- ref --><p><font size="2" face="Verdana">1. Cristofalo VJ: Emergent Theories of Ageing. In: Birren JE, Bengston VL, (Eds.), Springer, Berlin, 1988, pp. 118-127.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497829&pid=S0212-1611200700010001100001&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>2. Afanas'ev IB: Free radical mechanisms of aging processes under physiological conditions. Biogerontol 2005; 6:283-290.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497830&pid=S0212-1611200700010001100002&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>3. Harman D: Aging: a theory based on free radical and radiation chemistry. J Gerontol 1956; 11:298-300.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497831&pid=S0212-1611200700010001100003&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>4. Harman D: The aging process. Proc Natl Acad Sci USA 1981; 78:7124-7128.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497832&pid=S0212-1611200700010001100004&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>5. Luperchio S, Tamir S, Tannenbaum SR: NO-induced oxidative stress and glutathione metabolism in rodent and human cells. Free Radical Biol. Med 1996; 21:513-519.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497833&pid=S0212-1611200700010001100005&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>6. Cho CG, Kim HJ, Chung SW, Jung KJ, Shim KH, Yu BY, Yodoi J, Chung HY: Modulation of glutathione and thioredoxin systmes by calorie restriction during the aging process. Exp Gerontol 2003; 38:539-548.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497834&pid=S0212-1611200700010001100006&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>7. Payne JA, Reckelhoff JF, Khalil RA: Role of oxidative stress in age-related reduction of NO-cGMP-mediated vasicular relaxation in SHR. Am J Physiol Regul Integr Comp Physiol 2003; 285:R542-R551.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497835&pid=S0212-1611200700010001100007&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>8. Ames BN, Shigenaga MK, Hagen TM: Oxidant, antioxidants, and the degenerative diseases of aging. Proc Natl Acad Sci USA 1993; 90:7915-7922.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497836&pid=S0212-1611200700010001100008&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>9. Nehru B, Kanwar SS: N-acetylcysteine exposure on lead-induced lipid peroxidative damage and oxidative defense system in brain regions of rats. Biol Trace Elem Res 2004; 101:257-264.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497837&pid=S0212-1611200700010001100009&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>10. Ziment I: Acetylcysteine: a drug that is much more than a mucokinetic. Biomed Pharmacother 1988; 42:513-520.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497838&pid=S0212-1611200700010001100010&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>11. Kelly GS: Clinical applications of N-acetylcysteine. Alt Med Rev 1998; 3:114-127.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497839&pid=S0212-1611200700010001100011&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>12. Aruoma OI, Halliwell B, Hoey BM, Butler J: The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med 1989; 6:593-597.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497840&pid=S0212-1611200700010001100012&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>13. Wills ED: Mechanism of lipid peroxide formation in animal tissues. Biochem J 1966; 99:667-676.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497841&pid=S0212-1611200700010001100013&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>14. Ellman GL: Tissue sulfhydryl groups. Arch Biochim Biophys 1959; 82:70-77.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497842&pid=S0212-1611200700010001100014&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>15. Kono Y: Generation of superoxide radical during auto oxidation of hydroxylamine and an assay for superoxide dismutase. Arch Biochim Biophys 1978; 186:189-195.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497843&pid=S0212-1611200700010001100015&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>16. Luck H: Methods in enzymatic analysis, Academic Press, New York, 1971, pp. 885-893.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497844&pid=S0212-1611200700010001100016&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>17. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ: Protein measurement with the Follin-phenol reagent. J Biol Chem 1951; 193:265-275.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497845&pid=S0212-1611200700010001100017&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>18. Rodr&iacute;guez-Mart&iacute;nez MA, Alonso MJ, Redondo J, Salaices M, Mar&iacute;n J: Role of lipid peroxidation and the glutathione-dependent antioxidant system in the impairment of endothelium-dependent relaxations with age. British J Pharmacol 1998; 123: 113-121.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497846&pid=S0212-1611200700010001100018&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>19. Leutner S, Eckert A, Muller WE: ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain. J Neural Transm 2001; 108:955-967.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497847&pid=S0212-1611200700010001100019&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>20. Carlberg I, Mannervik B: Glutathione reductase. Methods Enzymol 1985; 113:484-490.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497848&pid=S0212-1611200700010001100020&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>21. Smith CD, Carney JM, Starke-Reed PE, Oliver CN, Stadtman ER, Floyd RA, Markesbery WR: Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease. Proc Natl Acad Sci USA 1991; 88: 10540-10543.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497849&pid=S0212-1611200700010001100021&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>22. Plaa GL, Witschi H: Chemicals, drugs and lipid peroxidation. Ann Rev Pharmacol Toxicol 1976; 16:125-141.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497850&pid=S0212-1611200700010001100022&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>23. Dringen R: Metabolism and functions of glutathione in brain. Prog Neurobiol 2000; 62:649-671.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497851&pid=S0212-1611200700010001100023&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>24. Ravindranath V, Shivakumar BR, Anandatheertha V: Low glutathione levels in brain regions of aged rats. Neurosci Lett 1989; 101:187-190.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497852&pid=S0212-1611200700010001100024&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>25. Hazelton A, Lang A: Glutathione contents of tissues in aging mouse. Biochem J 1980; 188:25-30.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497853&pid=S0212-1611200700010001100025&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>26. Corcoran GB, Todd EL, Racz WJ, Hughes H, Smith CV, Mitchell JR:Effects of N-acetylcysteine on the disposition and metabolism of acetaminophen in mice. J Pharmacol Exp Ther 1985; 32:857-863.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497854&pid=S0212-1611200700010001100026&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>27. De Flora S, Bennicelli C, Camoirano A, Serra D, Romano M, Rossi GA, Morelli A, De Flora A: In vivo effects of Nacetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds. Carcinogenesis 1985; 6:1735-1745.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497855&pid=S0212-1611200700010001100027&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>28. Hoffer E, Baum Y, Tabak A, Taitelman U: N-acetylcysteine increases the glutathione content and protects rat alveolar type II cells against paraquat-induced cytotoxicity. Toxicol Lett 1996; 84:7-12.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497856&pid=S0212-1611200700010001100028&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>29. Issels RD, Nagele A, Eckert KG, Wilmanna W: Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine. Biochem Pharnacol 1988; 37:881-888.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497857&pid=S0212-1611200700010001100029&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>30. Perez-Campo R, L&oacute;pez-Tarres M, Patin D, Eequeros E, Barja de QG: Lung antioxidant enzymes, peroxidation, glutathione system and oxygen consumption in catalase inactivated young and old Rana Perezi frogs. Mech Aging Dev 1990; 36:281-292.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497858&pid=S0212-1611200700010001100030&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>31. Tsay H, Wang P, Wang S, Ku H: Age-associated changes of superoxide dismutase and catalase activities in the rat brain. J Biomed Sci 2000; 7:466-474.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497859&pid=S0212-1611200700010001100031&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>32. Semsci I, Rao G, Richardson A: Expression of superoxide dismutase and catalase in rat brain as a function of age. Mech Aging Dev 1991; 58:13-19.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497860&pid=S0212-1611200700010001100032&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><!-- ref --><p>33. Sohal RS, Mockett RJ, Orr WC: Current issues concerning the role of oxidative stress in aging: a perspective. Results Probl Cell Differ 2000; 29:45-66.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;[&#160;<a href="javascript:void(0);" onclick="javascript: window.open('/scielo.php?script=sci_nlinks&ref=3497861&pid=S0212-1611200700010001100033&lng=','','width=640,height=500,resizable=yes,scrollbars=1,menubar=yes,');">Links</a>&#160;]<!-- end-ref --><p>&nbsp;</p>     <p>&nbsp;</p>     <p><a href="#top"><img border="0" src="/img/revistas/nh/v22n1/seta.gif" width="15" height="17"></a><b><a name="back"></a>Correspondence:</b>    <br> Dr. B. Nehru (Reader)    <br> Dept. of Biophysics    <br> Panjab University    <br> Chandigarh    <br> 160 014 India    ]]></body>
<body><![CDATA[<br> E-mail: <a href="mailto:sskanwar@gmail.com">sskanwar@gmail.com</a></font></p>      <p><font size="2" face="Verdana">Recibido: 19-V-2006.    <br> Aceptado: 6-XI-2006.</font></p>       ]]></body><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cristofalo]]></surname>
<given-names><![CDATA[VJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Emergent Theories of Ageing]]></article-title>
<person-group person-group-type="editor">
<name>
<surname><![CDATA[Birren]]></surname>
<given-names><![CDATA[JE]]></given-names>
</name>
<name>
<surname><![CDATA[Bengston]]></surname>
<given-names><![CDATA[VL]]></given-names>
</name>
</person-group>
<source><![CDATA[]]></source>
<year>1988</year>
<page-range>118-127</page-range><publisher-loc><![CDATA[Berlin ]]></publisher-loc>
<publisher-name><![CDATA[Springer]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Afanas'ev]]></surname>
<given-names><![CDATA[IB]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Free radical mechanisms of aging processes under physiological conditions]]></article-title>
<source><![CDATA[Biogerontol]]></source>
<year>2005</year>
<volume>6</volume>
<page-range>283-290</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Aging: a theory based on free radical and radiation chemistry]]></article-title>
<source><![CDATA[J Gerontol]]></source>
<year>1956</year>
<volume>11</volume>
<page-range>298-300</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Harman]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The aging process]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1981</year>
<volume>78</volume>
<page-range>7124-7128</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Luperchio]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tamir]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Tannenbaum]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[NO-induced oxidative stress and glutathione metabolism in rodent and human cells]]></article-title>
<source><![CDATA[Free Radical Biol. Med]]></source>
<year>1996</year>
<volume>21</volume>
<page-range>513-519</page-range></nlm-citation>
</ref>
<ref id="B6">
<label>6</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Cho]]></surname>
<given-names><![CDATA[CG]]></given-names>
</name>
<name>
<surname><![CDATA[Kim]]></surname>
<given-names><![CDATA[HJ]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[SW]]></given-names>
</name>
<name>
<surname><![CDATA[Jung]]></surname>
<given-names><![CDATA[KJ]]></given-names>
</name>
<name>
<surname><![CDATA[Shim]]></surname>
<given-names><![CDATA[KH]]></given-names>
</name>
<name>
<surname><![CDATA[Yu]]></surname>
<given-names><![CDATA[BY]]></given-names>
</name>
<name>
<surname><![CDATA[Yodoi]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Chung]]></surname>
<given-names><![CDATA[HY]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Modulation of glutathione and thioredoxin systmes by calorie restriction during the aging process]]></article-title>
<source><![CDATA[Exp Gerontol]]></source>
<year>2003</year>
<volume>38</volume>
<page-range>539-548</page-range></nlm-citation>
</ref>
<ref id="B7">
<label>7</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Payne]]></surname>
<given-names><![CDATA[JA]]></given-names>
</name>
<name>
<surname><![CDATA[Reckelhoff]]></surname>
<given-names><![CDATA[JF]]></given-names>
</name>
<name>
<surname><![CDATA[Khalil]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Role of oxidative stress in age-related reduction of NO-cGMP-mediated vasicular relaxation in SHR]]></article-title>
<source><![CDATA[Am J Physiol Regul Integr Comp Physiol]]></source>
<year>2003</year>
<volume>285</volume>
<page-range>R542-R551</page-range></nlm-citation>
</ref>
<ref id="B8">
<label>8</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ames]]></surname>
<given-names><![CDATA[BN]]></given-names>
</name>
<name>
<surname><![CDATA[Shigenaga]]></surname>
<given-names><![CDATA[MK]]></given-names>
</name>
<name>
<surname><![CDATA[Hagen]]></surname>
<given-names><![CDATA[TM]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Oxidant, antioxidants, and the degenerative diseases of aging]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1993</year>
<volume>90</volume>
<page-range>7915-7922</page-range></nlm-citation>
</ref>
<ref id="B9">
<label>9</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Nehru]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Kanwar]]></surname>
<given-names><![CDATA[SS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[N-acetylcysteine exposure on lead-induced lipid peroxidative damage and oxidative defense system in brain regions of rats]]></article-title>
<source><![CDATA[Biol Trace Elem Res]]></source>
<year>2004</year>
<volume>101</volume>
<page-range>257-264</page-range></nlm-citation>
</ref>
<ref id="B10">
<label>10</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ziment]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Acetylcysteine: a drug that is much more than a mucokinetic]]></article-title>
<source><![CDATA[Biomed Pharmacother]]></source>
<year>1988</year>
<volume>42</volume>
<page-range>513-520</page-range></nlm-citation>
</ref>
<ref id="B11">
<label>11</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kelly]]></surname>
<given-names><![CDATA[GS]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Clinical applications of N-acetylcysteine]]></article-title>
<source><![CDATA[Alt Med Rev]]></source>
<year>1998</year>
<volume>3</volume>
<page-range>114-127</page-range></nlm-citation>
</ref>
<ref id="B12">
<label>12</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Aruoma]]></surname>
<given-names><![CDATA[OI]]></given-names>
</name>
<name>
<surname><![CDATA[Halliwell]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Hoey]]></surname>
<given-names><![CDATA[BM]]></given-names>
</name>
<name>
<surname><![CDATA[Butler]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid]]></article-title>
<source><![CDATA[Free Radic Biol Med]]></source>
<year>1989</year>
<volume>6</volume>
<page-range>593-597</page-range></nlm-citation>
</ref>
<ref id="B13">
<label>13</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Wills]]></surname>
<given-names><![CDATA[ED]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Mechanism of lipid peroxide formation in animal tissues]]></article-title>
<source><![CDATA[Biochem J]]></source>
<year>1966</year>
<volume>99</volume>
<page-range>667-676</page-range></nlm-citation>
</ref>
<ref id="B14">
<label>14</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ellman]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Tissue sulfhydryl groups]]></article-title>
<source><![CDATA[Arch Biochim Biophys]]></source>
<year>1959</year>
<volume>82</volume>
<page-range>70-77</page-range></nlm-citation>
</ref>
<ref id="B15">
<label>15</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Kono]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Generation of superoxide radical during auto oxidation of hydroxylamine and an assay for superoxide dismutase]]></article-title>
<source><![CDATA[Arch Biochim Biophys]]></source>
<year>1978</year>
<volume>186</volume>
<page-range>189-195</page-range></nlm-citation>
</ref>
<ref id="B16">
<label>16</label><nlm-citation citation-type="book">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Luck]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<source><![CDATA[Methods in enzymatic analysis]]></source>
<year>1971</year>
<page-range>885-893</page-range><publisher-loc><![CDATA[New York ]]></publisher-loc>
<publisher-name><![CDATA[Academic Press]]></publisher-name>
</nlm-citation>
</ref>
<ref id="B17">
<label>17</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lowry]]></surname>
<given-names><![CDATA[OH]]></given-names>
</name>
<name>
<surname><![CDATA[Rosebrough]]></surname>
<given-names><![CDATA[NJ]]></given-names>
</name>
<name>
<surname><![CDATA[Farr]]></surname>
<given-names><![CDATA[AL]]></given-names>
</name>
<name>
<surname><![CDATA[Randall]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Protein measurement with the Follin-phenol reagent]]></article-title>
<source><![CDATA[J Biol Chem]]></source>
<year>1951</year>
<volume>193</volume>
<page-range>265-275</page-range></nlm-citation>
</ref>
<ref id="B18">
<label>18</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Rodríguez-Martínez]]></surname>
<given-names><![CDATA[MA]]></given-names>
</name>
<name>
<surname><![CDATA[Alonso]]></surname>
<given-names><![CDATA[MJ]]></given-names>
</name>
<name>
<surname><![CDATA[Redondo]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Salaices]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Marín]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Role of lipid peroxidation and the glutathione-dependent antioxidant system in the impairment of endothelium-dependent relaxations with age]]></article-title>
<source><![CDATA[British J Pharmacol]]></source>
<year>1998</year>
<volume>123</volume>
<page-range>113-121</page-range></nlm-citation>
</ref>
<ref id="B19">
<label>19</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Leutner]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Eckert]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Muller]]></surname>
<given-names><![CDATA[WE]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[ROS generation, lipid peroxidation and antioxidant enzyme activities in the aging brain]]></article-title>
<source><![CDATA[J Neural Transm]]></source>
<year>2001</year>
<volume>108</volume>
<page-range>955-967</page-range></nlm-citation>
</ref>
<ref id="B20">
<label>20</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Carlberg]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Mannervik]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Glutathione reductase]]></article-title>
<source><![CDATA[Methods Enzymol]]></source>
<year>1985</year>
<volume>113</volume>
<page-range>484-490</page-range></nlm-citation>
</ref>
<ref id="B21">
<label>21</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[CD]]></given-names>
</name>
<name>
<surname><![CDATA[Carney]]></surname>
<given-names><![CDATA[JM]]></given-names>
</name>
<name>
<surname><![CDATA[Starke-Reed]]></surname>
<given-names><![CDATA[PE]]></given-names>
</name>
<name>
<surname><![CDATA[Oliver]]></surname>
<given-names><![CDATA[CN]]></given-names>
</name>
<name>
<surname><![CDATA[Stadtman]]></surname>
<given-names><![CDATA[ER]]></given-names>
</name>
<name>
<surname><![CDATA[Floyd]]></surname>
<given-names><![CDATA[RA]]></given-names>
</name>
<name>
<surname><![CDATA[Markesbery]]></surname>
<given-names><![CDATA[WR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Excess brain protein oxidation and enzyme dysfunction in normal aging and in Alzheimer disease]]></article-title>
<source><![CDATA[Proc Natl Acad Sci USA]]></source>
<year>1991</year>
<volume>88</volume>
<page-range>10540-10543</page-range></nlm-citation>
</ref>
<ref id="B22">
<label>22</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Plaa]]></surname>
<given-names><![CDATA[GL]]></given-names>
</name>
<name>
<surname><![CDATA[Witschi]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Chemicals, drugs and lipid peroxidation]]></article-title>
<source><![CDATA[Ann Rev Pharmacol Toxicol]]></source>
<year>1976</year>
<volume>16</volume>
<page-range>125-141</page-range></nlm-citation>
</ref>
<ref id="B23">
<label>23</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dringen]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Metabolism and functions of glutathione in brain]]></article-title>
<source><![CDATA[Prog Neurobiol]]></source>
<year>2000</year>
<volume>62</volume>
<page-range>649-671</page-range></nlm-citation>
</ref>
<ref id="B24">
<label>24</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Ravindranath]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
<name>
<surname><![CDATA[Shivakumar]]></surname>
<given-names><![CDATA[BR]]></given-names>
</name>
<name>
<surname><![CDATA[Anandatheertha]]></surname>
<given-names><![CDATA[V]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Low glutathione levels in brain regions of aged rats]]></article-title>
<source><![CDATA[Neurosci Lett]]></source>
<year>1989</year>
<volume>101</volume>
<page-range>187-190</page-range></nlm-citation>
</ref>
<ref id="B25">
<label>25</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hazelton]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Lang]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Glutathione contents of tissues in aging mouse]]></article-title>
<source><![CDATA[Biochem J]]></source>
<year>1980</year>
<volume>188</volume>
<page-range>25-30</page-range></nlm-citation>
</ref>
<ref id="B26">
<label>26</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Corcoran]]></surname>
<given-names><![CDATA[GB]]></given-names>
</name>
<name>
<surname><![CDATA[Todd]]></surname>
<given-names><![CDATA[EL]]></given-names>
</name>
<name>
<surname><![CDATA[Racz]]></surname>
<given-names><![CDATA[WJ]]></given-names>
</name>
<name>
<surname><![CDATA[Hughes]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Smith]]></surname>
<given-names><![CDATA[CV]]></given-names>
</name>
<name>
<surname><![CDATA[Mitchell]]></surname>
<given-names><![CDATA[JR]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Effects of N-acetylcysteine on the disposition and metabolism of acetaminophen in mice]]></article-title>
<source><![CDATA[J Pharmacol Exp Ther]]></source>
<year>1985</year>
<volume>32</volume>
<page-range>857-863</page-range></nlm-citation>
</ref>
<ref id="B27">
<label>27</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[De Flora]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Bennicelli]]></surname>
<given-names><![CDATA[C]]></given-names>
</name>
<name>
<surname><![CDATA[Camoirano]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Serra]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Romano]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Rossi]]></surname>
<given-names><![CDATA[GA]]></given-names>
</name>
<name>
<surname><![CDATA[Morelli]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[De Flora]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[In vivo effects of Nacetylcysteine on glutathione metabolism and on the biotransformation of carcinogenic and/or mutagenic compounds]]></article-title>
<source><![CDATA[Carcinogenesis]]></source>
<year>1985</year>
<volume>6</volume>
<page-range>1735-1745</page-range></nlm-citation>
</ref>
<ref id="B28">
<label>28</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Hoffer]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Baum]]></surname>
<given-names><![CDATA[Y]]></given-names>
</name>
<name>
<surname><![CDATA[Tabak]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Taitelman]]></surname>
<given-names><![CDATA[U]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[N-acetylcysteine increases the glutathione content and protects rat alveolar type II cells against paraquat-induced cytotoxicity]]></article-title>
<source><![CDATA[Toxicol Lett]]></source>
<year>1996</year>
<volume>84</volume>
<page-range>7-12</page-range></nlm-citation>
</ref>
<ref id="B29">
<label>29</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Issels]]></surname>
<given-names><![CDATA[RD]]></given-names>
</name>
<name>
<surname><![CDATA[Nagele]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Eckert]]></surname>
<given-names><![CDATA[KG]]></given-names>
</name>
<name>
<surname><![CDATA[Wilmanna]]></surname>
<given-names><![CDATA[W]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Promotion of cystine uptake and its utilization for glutathione biosynthesis induced by cysteamine and N-acetylcysteine]]></article-title>
<source><![CDATA[Biochem Pharnacol]]></source>
<year>1988</year>
<volume>37</volume>
<page-range>881-888</page-range></nlm-citation>
</ref>
<ref id="B30">
<label>30</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Perez-Campo]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
<name>
<surname><![CDATA[López-Tarres]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Patin]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Eequeros]]></surname>
<given-names><![CDATA[E]]></given-names>
</name>
<name>
<surname><![CDATA[Barja de]]></surname>
<given-names><![CDATA[QG]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Lung antioxidant enzymes, peroxidation, glutathione system and oxygen consumption in catalase inactivated young and old Rana Perezi frogs]]></article-title>
<source><![CDATA[Mech Aging Dev]]></source>
<year>1990</year>
<volume>36</volume>
<page-range>281-292</page-range></nlm-citation>
</ref>
<ref id="B31">
<label>31</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Tsay]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[P]]></given-names>
</name>
<name>
<surname><![CDATA[Wang]]></surname>
<given-names><![CDATA[S]]></given-names>
</name>
<name>
<surname><![CDATA[Ku]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Age-associated changes of superoxide dismutase and catalase activities in the rat brain]]></article-title>
<source><![CDATA[J Biomed Sci]]></source>
<year>2000</year>
<volume>7</volume>
<page-range>466-474</page-range></nlm-citation>
</ref>
<ref id="B32">
<label>32</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Semsci]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Rao]]></surname>
<given-names><![CDATA[G]]></given-names>
</name>
<name>
<surname><![CDATA[Richardson]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Expression of superoxide dismutase and catalase in rat brain as a function of age]]></article-title>
<source><![CDATA[Mech Aging Dev]]></source>
<year>1991</year>
<volume>58</volume>
<page-range>13-19</page-range></nlm-citation>
</ref>
<ref id="B33">
<label>33</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sohal]]></surname>
<given-names><![CDATA[RS]]></given-names>
</name>
<name>
<surname><![CDATA[Mockett]]></surname>
<given-names><![CDATA[RJ]]></given-names>
</name>
<name>
<surname><![CDATA[Orr]]></surname>
<given-names><![CDATA[WC]]></given-names>
</name>
</person-group>
<article-title xml:lang="en"><![CDATA[Current issues concerning the role of oxidative stress in aging: a perspective. Results]]></article-title>
<source><![CDATA[Probl Cell Differ]]></source>
<year>2000</year>
<volume>29</volume>
<page-range>45-66</page-range></nlm-citation>
</ref>
</ref-list>
</back>
</article>
